Altimmune Inc (NASDAQ: ALT) kicked off on Monday, up 16.52% from the previous trading day, before settling in for the closing price of $3.51. Over the past 52 weeks, ALT has traded in a range of $2.90-$7.83.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 3.48%. While this was happening, its average annual earnings per share was recorded 27.05%. With a float of $103.61 million, this company’s outstanding shares have now reached $104.34 million.
Altimmune Inc (ALT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Altimmune Inc is 0.71%, while institutional ownership is 40.01%. The most recent insider transaction that took place on Dec 29 ’25, was worth 2,003. In this transaction Director of this company bought 527 shares at a rate of $3.80, taking the stock ownership to the 527 shares. Before that another transaction happened on Dec 23 ’25, when Company’s Director bought 12,500 for $4.10, making the entire transaction worth $51,250. This insider now owns 12,500 shares in total.
Altimmune Inc (ALT) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.33 earnings per share (EPS), higher than consensus estimate (set at -0.34) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.04% during the next five years compared to 3.48% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Take a look at Altimmune Inc’s (ALT) current performance indicators. Last quarter, stock had a quick ratio of 17.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21337.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.07, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
The latest stats from [Altimmune Inc, ALT] show that its last 5-days average volume of 8.51 million was inferior to 15.29 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 21.97%.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 27.61%, which indicates a significant decrease from 30.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.30 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.47, while its 200-day Moving Average is $4.57. Now, the first resistance to watch is $4.43. This is followed by the second major resistance level at $4.76. The third major resistance level sits at $5.00. If the price goes on to break the first support level at $3.86, it is likely to go to the next support level at $3.62. The third support level lies at $3.29 if the price breaches the second support level.
Altimmune Inc (NASDAQ: ALT) Key Stats
The company with the Market Capitalisation of 426.76 million has total of 104,342K Shares Outstanding. Its annual sales at the moment are 20 K in contrast with the sum of -95,060 K annual income. Company’s last quarter sales were recorded 10 K and last quarter income was -19,010 K.
